Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Neuroendocrine Tumors: Management and Updates

Integrity CE

R. Iyer

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Florida Gastroenterologic Society

D. Yang

Year in Review: Upper GI Cancers

Moffitt Cancer Center

R. Kim, R. Mehta

Medical Treatment for Hormone-Producing Tumors

Weill Cornell Medicine Courses and Meetings

S. Melmed

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

Sequencing Systemic Treatments for Well-Differentiated NETs

Integrity CE

J. Strosberg

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

Neuroendocrine Cancers: Background, Diagnosis, and Current Treatment

Total Health

R. Lentz

Imaging for Neuroendocrine Neoplasms

North American Neuroendocrine Tumor Society

G. Spilberg

SWOG S2012: 1L Chemo +/- Atezolizumab in Advanced Extrapulmonary Neu…

Fred Hutchinson Cancer Center

D. Zhen

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for …

2024 ASCO® Annual Meeting Insights Hub

J. Strosberg

NETs 101 and Overview of Medical Management

Yale Cancer Center

P. Kunz

ESMO 2024 Summary: Treatment Strategies and Sequencing in Carcinoid …

2024 ESMO Annual Meeting Insights Hub

R. Riechelmann

Gastric Cancer Clinical Standards

Houston Methodist

K. Allenson